Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients
ABSTRACT: Objective: To develop a multivariable clinical prediction model for the requirement of aggressive immunosuppression with cytostatics, based on simple clinical record data and lab tests. The model is defined in accordance with the result of the kidney biopsies. Methods: Retrospective study...
- Autores:
-
Restrepo Escobar, Mauricio
Granda Carvajal, Paula Andrea
Jaimes Barragán, Fabian Alberto
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2019
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/29831
- Acceso en línea:
- https://hdl.handle.net/10495/29831
- Palabra clave:
- Lupus Eritematoso Sistémico
Lupus Erythematosus, Systemic
Técnicas de Apoyo para la Decisión
Decision Support Techniques
Modelos Logísticos
Logistic Models
Nefritis Lúpica
Lupus Nephritis
Análisis Multivariante
Multivariate Analysis
Inmunosupresión
Immunosuppression
Tolerancia Inmunológica
Immune Tolerance
- Rights
- openAccess
- License
- http://creativecommons.org/licenses/by/2.5/co/
id |
UDEA2_a68df417b91bf92d1f30ad8bc20b8d7d |
---|---|
oai_identifier_str |
oai:bibliotecadigital.udea.edu.co:10495/29831 |
network_acronym_str |
UDEA2 |
network_name_str |
Repositorio UdeA |
repository_id_str |
|
dc.title.spa.fl_str_mv |
Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients |
dc.title.alternative.spa.fl_str_mv |
Desarrollo y validación interna de un modelo de predicción para estimar la probabilidad de requerir inmunosupresión intensiva con citostáticos en pacientes con nefritis lúpica de novo |
title |
Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients |
spellingShingle |
Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients Lupus Eritematoso Sistémico Lupus Erythematosus, Systemic Técnicas de Apoyo para la Decisión Decision Support Techniques Modelos Logísticos Logistic Models Nefritis Lúpica Lupus Nephritis Análisis Multivariante Multivariate Analysis Inmunosupresión Immunosuppression Tolerancia Inmunológica Immune Tolerance |
title_short |
Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients |
title_full |
Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients |
title_fullStr |
Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients |
title_full_unstemmed |
Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients |
title_sort |
Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients |
dc.creator.fl_str_mv |
Restrepo Escobar, Mauricio Granda Carvajal, Paula Andrea Jaimes Barragán, Fabian Alberto |
dc.contributor.author.none.fl_str_mv |
Restrepo Escobar, Mauricio Granda Carvajal, Paula Andrea Jaimes Barragán, Fabian Alberto |
dc.subject.decs.none.fl_str_mv |
Lupus Eritematoso Sistémico Lupus Erythematosus, Systemic Técnicas de Apoyo para la Decisión Decision Support Techniques Modelos Logísticos Logistic Models Nefritis Lúpica Lupus Nephritis Análisis Multivariante Multivariate Analysis Inmunosupresión Immunosuppression Tolerancia Inmunológica Immune Tolerance |
topic |
Lupus Eritematoso Sistémico Lupus Erythematosus, Systemic Técnicas de Apoyo para la Decisión Decision Support Techniques Modelos Logísticos Logistic Models Nefritis Lúpica Lupus Nephritis Análisis Multivariante Multivariate Analysis Inmunosupresión Immunosuppression Tolerancia Inmunológica Immune Tolerance |
description |
ABSTRACT: Objective: To develop a multivariable clinical prediction model for the requirement of aggressive immunosuppression with cytostatics, based on simple clinical record data and lab tests. The model is defined in accordance with the result of the kidney biopsies. Methods: Retrospective study conducted with data from patients 16 years and older, with SLE and nephritis with less than 6 months of evolution. An initial bivariate analysis was conducted to select the variables to be included in a multiple logistic regression model. Goodness of fit was evaluated using a Hosmer–Lemeshow test (H–L) and the discrimination capacity of the model by means of the area under the ROC (AUC) curve. Results Data from 242 patients was gathered; of these, 18.2% (n=44) did not need an addition of cytostatics according to the findings of their kidney biopsies. The variables included in the final model were 24-h proteinuria, diastolic blood pressure, creatinine, C3 complement and the interaction of hematuria with leukocyturia in urinary sediment. The model showed excellent discrimination (AUC=0.929; 95% CI=0.894–0.963) and adequate calibration (H–L, P=.959). Conclusion In recent-onset LN patients, the decision to use or not to use intensive immunosuppressive therapy could be performed based on our prediction model as an alternative to kidney biopsies. |
publishDate |
2019 |
dc.date.issued.none.fl_str_mv |
2019 |
dc.date.accessioned.none.fl_str_mv |
2022-07-22T15:29:14Z |
dc.date.available.none.fl_str_mv |
2022-07-22T15:29:14Z |
dc.type.spa.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.hasversion.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.redcol.spa.fl_str_mv |
https://purl.org/redcol/resource_type/ART |
dc.type.local.spa.fl_str_mv |
Artículo de investigación |
format |
http://purl.org/coar/resource_type/c_2df8fbb1 |
status_str |
publishedVersion |
dc.identifier.citation.spa.fl_str_mv |
Restrepo-Escobar M, Granda-Carvajal PA, Jaimes F. Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients. Reumatol Clin (Engl Ed). 2019 Jan-Feb;15(1):27-33. |
dc.identifier.issn.none.fl_str_mv |
1699-258X |
dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/10495/29831 |
dc.identifier.doi.none.fl_str_mv |
10.1016/j.reuma.2017.05.010 |
dc.identifier.eissn.none.fl_str_mv |
1885-1398 |
identifier_str_mv |
Restrepo-Escobar M, Granda-Carvajal PA, Jaimes F. Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients. Reumatol Clin (Engl Ed). 2019 Jan-Feb;15(1):27-33. 1699-258X 10.1016/j.reuma.2017.05.010 1885-1398 |
url |
https://hdl.handle.net/10495/29831 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartofjournalabbrev.spa.fl_str_mv |
Reumatol. Clín. |
dc.rights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by/2.5/co/ |
dc.rights.accessrights.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.creativecommons.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by/2.5/co/ http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.format.extent.spa.fl_str_mv |
7 |
dc.format.mimetype.spa.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Sociedad Española de Reumatología Colegio Mexicano de Reumatología Elsevier |
dc.publisher.group.spa.fl_str_mv |
Grupo Académico de Epidemiología Clínica Grupo de Reumatología Universidad de Antioquia -GRUA- |
dc.publisher.place.spa.fl_str_mv |
Barcelona, España |
institution |
Universidad de Antioquia |
bitstream.url.fl_str_mv |
https://bibliotecadigital.udea.edu.co/bitstream/10495/29831/1/RestrepoMauricio_2019_ImmunosuppressiveCytostaticsLupus.pdf https://bibliotecadigital.udea.edu.co/bitstream/10495/29831/2/license_rdf https://bibliotecadigital.udea.edu.co/bitstream/10495/29831/3/license.txt |
bitstream.checksum.fl_str_mv |
7ac80f4e6dc90c9208ba5e2fb56b360f 1646d1f6b96dbbbc38035efc9239ac9c 8a4605be74aa9ea9d79846c1fba20a33 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Institucional Universidad de Antioquia |
repository.mail.fl_str_mv |
andres.perez@udea.edu.co |
_version_ |
1812173204486094848 |
spelling |
Restrepo Escobar, MauricioGranda Carvajal, Paula AndreaJaimes Barragán, Fabian Alberto2022-07-22T15:29:14Z2022-07-22T15:29:14Z2019Restrepo-Escobar M, Granda-Carvajal PA, Jaimes F. Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis Patients. Reumatol Clin (Engl Ed). 2019 Jan-Feb;15(1):27-33.1699-258Xhttps://hdl.handle.net/10495/2983110.1016/j.reuma.2017.05.0101885-1398ABSTRACT: Objective: To develop a multivariable clinical prediction model for the requirement of aggressive immunosuppression with cytostatics, based on simple clinical record data and lab tests. The model is defined in accordance with the result of the kidney biopsies. Methods: Retrospective study conducted with data from patients 16 years and older, with SLE and nephritis with less than 6 months of evolution. An initial bivariate analysis was conducted to select the variables to be included in a multiple logistic regression model. Goodness of fit was evaluated using a Hosmer–Lemeshow test (H–L) and the discrimination capacity of the model by means of the area under the ROC (AUC) curve. Results Data from 242 patients was gathered; of these, 18.2% (n=44) did not need an addition of cytostatics according to the findings of their kidney biopsies. The variables included in the final model were 24-h proteinuria, diastolic blood pressure, creatinine, C3 complement and the interaction of hematuria with leukocyturia in urinary sediment. The model showed excellent discrimination (AUC=0.929; 95% CI=0.894–0.963) and adequate calibration (H–L, P=.959). Conclusion In recent-onset LN patients, the decision to use or not to use intensive immunosuppressive therapy could be performed based on our prediction model as an alternative to kidney biopsies.RESUMEN: Objetivo: Desarrollar un modelo multivariado de predicción clínica basado en datos sencillos de la historia clínica y de las pruebas de laboratorio de la necesidad de inmunosupresión intensiva con citostáticos, definida de acuerdo con el resultado de la biopsia renal, en pacientes con LES y nefritis de reciente inicio. Metodología: Se realizó un estudio retrospectivo en 2 hospitales de tercer nivel en el que se recolectó información de pacientes mayores de 16 anos ˜ con LES y nefritis de menos de 6 meses de evolución. Se realizó un análisis bivariado inicial para seleccionar las variables a incluir en un modelo de regresión logística múltiple. Se evaluó la bondad de ajuste por medio del estadístico de Hosmer–Lemeshow (H-L) y la capacidad de discriminación del modelo mediante área bajo la curva ROC (AUC). Resultados: Se recolectó información de 242 pacientes, de los cuales el 18,2% (n = 44) no necesitaba tratamiento intensivo con citostáticos de acuerdo con los hallazgos de la biopsia renal. Las variables incluidas en el modelo final fueron proteinuria en 24 h, presión arterial diástolica, creatinina, complemento C3 y la combinación de hematuria con leucocituria presentes en el análisis del sedimento urinario. El modelo mostró una excelente capacidad de discriminación (AUC = 0,929; IC del 95% = 0,894–0,963) y adecuada calibración (H-L = 0,959). Conclusión: En pacientes con NL de reciente inicio, la decisión de usar o no terapia inmunosupresora intensiva podría ser realizada sobre la base de nuestro modelo de predicción como una alternativa a la biopsia renal.COL0010959COL00071217application/pdfengSociedad Española de ReumatologíaColegio Mexicano de ReumatologíaElsevierGrupo Académico de Epidemiología ClínicaGrupo de Reumatología Universidad de Antioquia -GRUA-Barcelona, Españainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTArtículo de investigaciónhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/2.5/co/http://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by-nc-nd/4.0/Development and Internal Validation of a Prediction Model to Estimate the Probability of Needing Aggressive Immunosuppressive Therapy With Cytostatics in de Novo Lupus Nephritis PatientsDesarrollo y validación interna de un modelo de predicción para estimar la probabilidad de requerir inmunosupresión intensiva con citostáticos en pacientes con nefritis lúpica de novoLupus Eritematoso SistémicoLupus Erythematosus, SystemicTécnicas de Apoyo para la DecisiónDecision Support TechniquesModelos LogísticosLogistic ModelsNefritis LúpicaLupus NephritisAnálisis MultivarianteMultivariate AnalysisInmunosupresiónImmunosuppressionTolerancia InmunológicaImmune ToleranceReumatol. Clín.Reumatología Clínica2733151ORIGINALRestrepoMauricio_2019_ImmunosuppressiveCytostaticsLupus.pdfRestrepoMauricio_2019_ImmunosuppressiveCytostaticsLupus.pdfArtículo de investigaciónapplication/pdf323443https://bibliotecadigital.udea.edu.co/bitstream/10495/29831/1/RestrepoMauricio_2019_ImmunosuppressiveCytostaticsLupus.pdf7ac80f4e6dc90c9208ba5e2fb56b360fMD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8927https://bibliotecadigital.udea.edu.co/bitstream/10495/29831/2/license_rdf1646d1f6b96dbbbc38035efc9239ac9cMD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstream/10495/29831/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD5310495/29831oai:bibliotecadigital.udea.edu.co:10495/298312022-07-22 10:29:15.013Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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 |